May 22, 2020

Cell therapy weekly: unproven ‘stem cell-based treatments’ for COVID-19 – are some businesses taking advantage of public fears?

Posted by in categories: biotech/medical, business

This week: Be The Match BioTherapies® (MN, USA) and NantKwest (CA, USA) collaborate to help progress a potential cell therapy for COVID-19-associated ARDS and a new platform from WuXi Advanced Therapies (PA, USA) may help accelerate cell and gene therapy development.

Go to the profile of RegMedNet

ECommunity, Future Science Group

Comments are closed.